Multi-phase, patient navigator-based program in the Richmond and Tidewater regions of Virginia to demonstrate:
- the feasibility of using patient navigators to improve the percentage of adult (age 15 and older) patients with sickle cell disease (SCD) in SCD specialty care
- the efficacy of using patient navigators to improve hydroxyurea (HU) (re-)initiation and adherence among adult patients with SCD eligible for HU
(Patient navigators may also be known as public health workers.)
More information: clinicaltrials.gov, ITHANET Clinical Trials